• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Author response to: Comment on: Predictive value of pretreatment circulating inflammatory response markers in the neoadjuvant treatment of breast cancer: meta-analysis.作者对《关于乳腺癌新辅助治疗中预处理循环炎症反应标志物的预测价值：荟萃分析》评论的回应
Br J Surg. 2024 Jul 2;111(7). doi: 10.1093/bjs/znae190.
2
Comment on: Predictive value of pretreatment circulating inflammatory response markers in the neoadjuvant treatment of breast cancer: meta-analysis.评论：乳腺癌新辅助治疗中预处理循环炎症反应标志物的预测价值：荟萃分析。
Br J Surg. 2024 Jul 2;111(7). doi: 10.1093/bjs/znae187.
3
Predictive value of pretreatment circulating inflammatory response markers in the neoadjuvant treatment of breast cancer: meta-analysis.术前循环炎症反应标志物在乳腺癌新辅助治疗中的预测价值：荟萃分析。
Br J Surg. 2024 May 3;111(5). doi: 10.1093/bjs/znae132.
4
The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients.新辅助治疗前后系统性免疫炎症标志物对乳腺癌患者病理完全缓解的预测价值：1994 例患者的回顾性研究。
Clin Transl Oncol. 2024 Jun;26(6):1467-1479. doi: 10.1007/s12094-023-03371-7. Epub 2024 Jan 8.
5
Multiple time points for detecting circulating tumor DNA to monitor the response to neoadjuvant therapy in breast cancer: a meta-analysis.检测循环肿瘤DNA以监测乳腺癌新辅助治疗反应的多个时间点：一项荟萃分析
BMC Cancer. 2025 Jan 22;25(1):115. doi: 10.1186/s12885-025-13526-0.
6
Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer.探索循环微小RNA在乳腺癌新辅助治疗中的作用
Int J Cancer. 2016 Jul 1;139(1):12-22. doi: 10.1002/ijc.29985. Epub 2016 Jan 30.
7
Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy.新辅助化疗期间乳腺癌患者循环免疫原性细胞死亡生物标志物HMGB1和RAGE
Tumour Biol. 2013 Feb;34(1):81-90. doi: 10.1007/s13277-012-0513-1. Epub 2012 Sep 15.
8
Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.血清肿瘤标志物水平在评估局部晚期乳腺癌新辅助治疗反应中可能意义不大。
Asian Pac J Cancer Prev. 2015;16(11):4603-8. doi: 10.7314/apjcp.2015.16.11.4603.
9
Laboratory indicators predict axillary nodal pathologic complete response after neoadjuvant therapy in breast cancer.实验室指标预测乳腺癌新辅助治疗后腋窝淋巴结病理完全缓解。
Future Oncol. 2021 Jul;17(19):2449-2460. doi: 10.2217/fon-2020-1231. Epub 2021 Apr 21.
10
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.外泌体 miRNA 谱作为新辅助化疗局部乳腺癌诊断和预测治疗反应的补充工具。
Breast Cancer Res. 2019 Feb 6;21(1):21. doi: 10.1186/s13058-019-1109-0.

本文引用的文献

1
Comment on: Predictive value of pretreatment circulating inflammatory response markers in the neoadjuvant treatment of breast cancer: meta-analysis.评论：乳腺癌新辅助治疗中预处理循环炎症反应标志物的预测价值：荟萃分析。
Br J Surg. 2024 Jul 2;111(7). doi: 10.1093/bjs/znae187.
2
Predictive value of pretreatment circulating inflammatory response markers in the neoadjuvant treatment of breast cancer: meta-analysis.术前循环炎症反应标志物在乳腺癌新辅助治疗中的预测价值：荟萃分析。
Br J Surg. 2024 May 3;111(5). doi: 10.1093/bjs/znae132.
3
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.《流行病学观察性研究报告强化（STROBE）声明》：观察性研究报告指南
Lancet. 2007 Oct 20;370(9596):1453-7. doi: 10.1016/S0140-6736(07)61602-X.
4
The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey.荟萃分析中用于发表偏倚的不对称性检验的适用性：一项大型调查。
CMAJ. 2007 Apr 10;176(8):1091-6. doi: 10.1503/cmaj.060410.
5
Comparison of two methods to detect publication bias in meta-analysis.两种用于检测Meta分析中发表偏倚的方法比较
JAMA. 2006 Feb 8;295(6):676-80. doi: 10.1001/jama.295.6.676.
6
Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature.Meta分析中的发表偏倚及相关偏倚：统计检验效能与文献中的患病率
J Clin Epidemiol. 2000 Nov;53(11):1119-29. doi: 10.1016/s0895-4356(00)00242-0.

Author response to: Comment on: Predictive value of pretreatment circulating inflammatory response markers in the neoadjuvant treatment of breast cancer: meta-analysis.

作者信息

Dowling Gavin P, Daly Gordon R, Hegarty Aisling, Hembrecht Sandra, Bracken Aisling, Toomey Sinead, Hennessy Bryan T, Hill Arnold D K

机构信息

Department of Surgery, Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences, Dublin, Ireland.

Medical Oncology Lab, Department of Molecular Medicine, Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences, Dublin, Ireland.

出版信息

Br J Surg. 2024 Jul 2;111(7). doi: 10.1093/bjs/znae190.

DOI:10.1093/bjs/znae190
PMID:39051666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11270116/
Abstract
摘要